News AZ sells migraine drug rights to Grunenthal for $300m AZ says migraine outside its strategic focus.
News Data keeps Lilly in race for new migraine treatment Company still in race to develop CGRP inhibitor for migraine.
News Novartis/Amgen migraine drug shows promise Mid-stage data suggests drug reduces monthly migraine days.
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
